Investigation of the efficacy of imidazolyl ethanamide pentandioic acid (IEPA) to reduce chemotherapy-induced myelosuppression (CIM) in breast cancer patients.

Frank Mayer,Dirk Pleimes,Marcus Schmidt,Peter A. Fasching,Christian Jackisch,Kathrin Flunkert,Corinna Asang,Florence Razoux,Volker Moebus

Investigation of the efficacy of imidazolyl ethanamide pentandioic acid (IEPA) to reduce chemotherapy-induced myelosuppression (CIM) in breast cancer patients.

2019

Frank Mayer
Dirk Pleimes
Marcus Schmidt
Peter A. Fasching
Christian Jackisch
Kathrin Flunkert
Corinna Asang
Florence Razoux
Volker Moebus

e23098Background: Neutropenia is a major toxicity of myelosuppressive chemotherapy (CTX). Treatment and prophylaxis of CTX-induced neutropenia with granulocyte colony-stimulating factors is mainly ...

Keywords:

IMIDAZOLYL ETHANAMIDE PENTANDIOIC ACID
Breast cancer
Oncology
Pathology
Medicine
Internal medicine
Chemotherapy
Myelosuppressive Chemotherapy
Neutropenia
chemotherapy induced
Toxicity
Granulocyte

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations